GlassScriptPhysician profile
Puja B Parikh
NPI 1649415290
$35,753.59
in general payments reported to CMS, 2019-2025
22 companies · $4,525 in 2025
The $4,525 reported for 2025 was more than what 91% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $6,856 · 2020: $774 · 2021: $472 · 2022: $3,692 · 2023: $4,408 · 2024: $15K · 2025: $4,525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $17K · Travel and Lodging: $3,306 · Food and Beverage: $3,298 · Consulting Fee: $475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $16,881.25 |
| Travel and Lodging | $3,306.21 |
| Food and Beverage | $3,298.10 |
| Consulting Fee | $475.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $24,566.07 | 2021-2025 | Corevalve Evolut R, Symplicity G3 |
| Medtronic Vascular, INC. | $6,109.63 | 2019-2020 | |
| Abbott Laboratories | $2,477.71 | 2019-2025 | Triclip, Mitraclip, Amplatzer |
| Abiomed | $813.40 | 2019-2025 | Impella |
| Shockwave Medical, INC | $467.06 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Edwards Lifesciences Corporation | $417.37 | 2019-2025 | Sapien 3 Ultra Resilia, Pascal |
| Astrazeneca Pharmaceuticals LP | $150.94 | 2019-2025 | Farxiga |
| Philips North America LLC | $141.89 | 2019 | |
| Boston Scientific Corporation | $135.05 | 2019-2023 | Watchman Access System |
| Pfizer INC. | $108.59 | 2022-2025 | |
| Cardiva Medical, INC. | $88.19 | 2022-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 5f Vcs |
| Amgen INC. | $58.03 | 2022-2024 | Repatha |
| Chiesi USA, INC. | $49.38 | 2019-2024 | Kengreal, Cleviprex |
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.05 | 2023 | Jardiance |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $39.27 | 2023 | Lifevest |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $24.03 | 2025 | Gore Cardioform Septal Occluder |
| Heartflow, INC. | $18.83 | 2024 | |
| B. Braun Interventional Systems INC. | $17.71 | 2021 | |
| Idorsia Pharmaceuticals US INC | $15.88 | 2025 | Tryvio |
| Cardinal Health 200 LLC | $14.51 | 2020 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Puja Parikh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.